Cutting-edge mass spectrometry characterization of originator, biosimilar and biobetter antibodies-Reference-Cited by-同舟云学术

Cutting-edge mass spectrometry characterization of originator, biosimilar and biobetter antibodies

Published:2015-02 Issue:2 Volume:50 Page:285-297
ISSN:1076-5174
Container-title:Journal of Mass Spectrometry
language:en
Short-container-title:J. Mass Spectrom.

Author:

Beck Alain¹,Debaene François²,Diemer Hélène²,Wagner-Rousset Elsa¹,Colas Olivier¹,Dorsselaer Alain Van²,Cianférani Sarah²

Affiliation:

1. Centre d'Immunologie Pierre Fabre (CIPF); 5 Av. Napoléon III, BP 60497 74164 Saint-Julien-en-Genevois France

2. Laboratoire de Spectrométrie de Masse BioOrganique (LSMBO); Université de Strasbourg, IPHC; 25 rue Becquerel 67087 Strasbourg, France. CNRS, UMR7178 67087 Strasbourg France

Publisher

Wiley

Subject

Spectroscopy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jms.3554/fullpdf

Reference53 articles.

3. Setting the stage for biosimilar monoclonal antibodies;Schneider;Nat.Biotechnol.,2012

4. European Medicines Agency workshop on biosimilar monoclonal antibodies: July 2, 2009, London UK;Reichert;MAbs,2009

5. Approval of the first biosimilar antibodies in Europe: a major landmark for the biopharmaceutical industry;Beck;MAbs,2013

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural Characterization of Monoclonal Antibodies and Epitope Mapping by FFAP Footprinting;Analytical Chemistry;2024-05-03

2. Influence of pneumatic transportation on the stability of monoclonal antibodies;Scientific Reports;2023-12-10

3. Recent advances in structural mass spectrometry methods in the context of biosimilarity assessment: from sequence heterogeneities to higher order structures;Journal of Pharmaceutical and Biomedical Analysis;2023-11

4. Recent applications of quantitative mass spectrometry in biopharmaceutical process development and manufacturing;Journal of Pharmaceutical and Biomedical Analysis;2023-09

5. Why is there no biosimilar of Erbitux®?;Journal of Pharmaceutical and Biomedical Analysis;2023-09